Role of probiotics and functional foods in health: Gut immune stimulation by two probiotic strains and a potential probiotic yoghurt

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 15, Issue 1, 2015, Pages 37-45

  Galdeano, Carolina Maldonado ^a,b   Nuñez, Ivanna Novotny ^a   Carmuega, Esteban ^c   de LeBlanc, Alejandra de Moreno ^a   Perdigón, Gabriela ^a,b  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^c Child Nutrition Study Center Dr Alejandro o'Donnell   (Argentina)

Author keywords

Mucosal immunity; Probiotic; Probiotic claims; Probiotic fermented milk; Systemic immunity

Indexed keywords

CALCINEURIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; YOGHURT;

ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; DENDRITIC CELL; ENTERITIS; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; FUNCTIONAL FOOD; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MALNUTRITION; SALMONELLA; ANIMAL; GASTRIC MUCOSA; HEALTH STATUS; IMMUNOLOGY; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; FUNCTIONAL FOOD; GASTRIC MUCOSA; GASTROINTESTINAL MICROBIOME; HEALTH STATUS; HUMANS; PROBIOTICS; YOGURT;

EID: 84930905750     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/1871530314666141216121349     Document Type: Article

References (65)

1. Candela, M.; Biagi E.; Maccaferri S.; Turroni S. and Brigidi P. (2012) Intestinal microbiota is a plastic factor responding to environmental changes. Trends Microbiol., 20, 385-391.
2. Bailey, M.T. (2012) The contributing role of the intestinal microbiota in stressor-induced increases in susceptibility to enteric infection and systemic immunomodulation. Horm. Behav., 62, 286- 294.
3. FAO/WHO (2001) Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report. Available from http://www.fao.org/ag/ agn/agns/micro_probiotics_en.asp.
4. Zhang, J.W.; Du, P.; Gao, J.; Yang, B.R.; Fang, W.J. and Ying, C.M. (2012) Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. Am. J. Med. Sci., 343, 199-205.
5. de Moreno de LeBlanc, A. and Perdigon, G. (2010) The application of probiotic fermented milks in cancer and intestinal inflammation. Proc. Nutr. Soc., 69, 421-428.
6. Escamilla, J.; Lane M.A. and Maitin V. (2012) Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr. Cancer, 64, 871-878.
7. Almeida, C.C.; Lorena S.L.; Pavan C.R.; Akasaka H.M. and Mesquita, M.A. (2012) Beneficial effects of long-term consumption of a probiotic combination of Lactobacillus casei Shirota and Bifidobacterium breve Yakult may persist after suspension of therapy in lactose-intolerant patients. Nutr. Clin. Pract., 27, 247-251.
8. Kuitunen, M. and Boyle R.J. (2012) Probiotics for the prevention of allergic disease. Clin. Exp. Allergy, 42, 991-993.
9. Pot, B.; Foligne, B.; Daniel, C. and Grangette C (2013) Understanding immunomodulatory effects of probiotics. Nestle Nutr. Inst. Workshop Ser., 77, 75-90
10. Ashraf, R. and Shah, N.P. (2014) Immune system stimulation by probiotic microorganisms. Crit. Rev. Food Sci. Nutr., 54, 938-956
11. Hardy, H.; Harris, J.; Lyon, E.; Beal, J. and Foey, A.D. (2013) Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients, 5, 1869- 1912
12. Bezkorovainy, A. (2001) Probiotics: Determinants of survival and growth in the gut. Am. J. Clin. Nutr., 73, 399S-405S.
13. Galdeano, C.M. and Perdigon, G. (2004) Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J. Appl. Microbiol., 97, 673-681.
14. Galdeano, C.M.; de Moreno de LeBlanc, A.; Carmuega, E.; Weill, R. and Perdigon, G. (2009) Mechanisms involved in the immunostimulation by probiotic fermented milk. J. Dairy Res., 76, 446-454.
15. Haller, D.; Bode, C.; Hammes, W.P.; Pfeifer, A.M.; Schiffrin, E.J. and Blum S. (2000) Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut, 47, 79-87.
16. Dogi, C.A.; Galdeano, C.M. and Perdigon, G. (2008) Gut immune stimulation by non pathogenic Gram(+) and Gram(-) bacteria. Comparison with a probiotic strain. Cytokine, 41, 223-231.
17. Vinderola, G.; Matar C. and Perdigon G. (2005) Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: Involvement of Toll-like receptors. Clin. Diagn. Lab. Immunol., 12, 1075-1084.
18. Beagley, K.W.; Eldridge, J.H.; Aicher, W.K.; Mestecky, J.; Di Fabio, S.; Kiyono, H. and McGhee, J.R. (1991) Peyer's patch b cells with memory cell characteristics undergo terminal differentiation within 24 hours in response to interleukin-6. Cytokine, 3, 107-116.
19. Jang, M.H.; Kweon, M.N.; Iwatani, K.; Yamamoto, M.; Terahara, K.; Sasakawa, C.; Suzuki, T.; Nochi, T.; Yokota, Y.; Rennert, P.D.; Hiroi, T.; Tamagawa, H.; Iijima, H.; Kunisawa, J.; Yuki, Y. and Kiyono, H. (2004) Intestinal villous M cells: An antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. USA, 101, 6110- 6115.
20. Rescigno, M.; Urbano, M.; Valzasina, B.; Francolini, M.; Rotta, G.; Bonasio, R.; Granucci, F.; Kraehenbuhl, J.P. and Ricciardi- Castagnoli, P. (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol., 2, 361-367.
21. Mack, D.R.; Michail S.; Wei S.; McDougall L. and Hollingsworth M.A. (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol., 276, G941-G950.
22. Galdeano, C.M.; de Moreno de LeBlanc, A.; Vinderola, G.; Bonet, M.E. and Perdigon, G. (2007) Proposed model: Mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vaccine. Immunol., 14, 485-492.
23. de Moreno de LeBlanc, A.; Galdeano C.M.; Chaves, S. and Perdigon, G. (2005) Oral administration of Lactobacillus casei CRL 431 increases immunity in bronchus and mammary glands. Eur. J. Inflamm., 3, 23-28.
24. de Moreno de Leblanc, A.; Chaves S.; Carmuega E.; Weill R.; Antoine J. and Perdigon G. (2008) Effect of long-term continuous consumption of fermented milk containing probiotic bacteria on mucosal immunity and the activity of peritoneal macrophages. Immunobiology, 213, 97-108.
25. Galdeano, C.M. and Perdigon G. (2006) The probiotic bacterium lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol., 13, 219-226.
26. Wijburg, O.L.; Heemskerk M.H.; Boog C.J. and Van Rooijen N. (1997) Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain a59. Immunol, 92, 252-258.
27. Wen, H.; Schaller, M.A.; Dou, Y.; Hogaboam, C.M. and Kunkel, S.L. (2008) Dendritic cells at the interface of innate and acquired immunity: The role for epigenetic changes. J. Leukoc. Biol., 83, 439-446.
28. Kaminuma, O.; Kitamura, F.; Kitamura, N.; Hiroi, T.; Miyoshi, H.; Miyawaki, A. and Miyatake, S. (2008) Differential contribution of NFATC2 and NFATC1 to TNF-alpha gene expression in T cells. J, Immunol., 180, 319-326.
29. Tsuboi, A.; Masuda, E.S.; Naito, Y.; Tokumitsu, H.; Arai, K. and Arai, N. (1994) Calcineurin potentiates activation of the granulocyte-macrophage colony-stimulating factor gene in t cells: Involvement of the conserved lymphokine element 0. Mol. Biol. Cell, 5, 119-128.
30. Feghali, C.A. and Wright T.M. (1997) Cytokines in acute and chronic inflammation. Front Biosci., 2, d12-26.
31. Rizza, P.; Ferrantini M.; Capone I. and Belardelli F. (2002) Cytokines as natural adjuvants for vaccines: Where are we now? Trends Immunol., 23, 381-383.
32. Frucht, D.M.; Fukao, T.; Bogdan, C.; Schindler, H.; O'Shea, J.J. and Koyasu, S. (2001) Ifngamma production by antigen-presenting cells: Mechanisms emerge. Trends Immunol., 22, 556-560.
33. McKenzie, B.S.; Kastelein R.A. and Cua D.J. (2006) Understanding the Il-23-Il-17 immune pathway. Trends Immunol., 27, 17-23.
34. Sydora, B.C.; Tavernini, M.M.; Wessler, A.; Jewell, L.D. and Fedorak, R.N. (2003) Lack of interleukin-10 leads to intestinal inflammation, independent of the time at which luminal microbial colonization occurs. Inflamm. Bowel. Dis., 9, 87-97.
35. Roux, E.; Dumont-Girard, F.; Starobinski, M.; Siegrist, C.A.; Helg, C.; Chapuis, B. and Roosnek, E. (2000) Recovery of immune reactivity after t-cell-depleted bone marrow transplantation depends on thymic activity. Blood, 96, 2299-2303.
36. de Moreno de LeBlanc, A.; Matar, C.; Theriault, C. and Perdigon, G. (2005) Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiol., 210, 349-358.
37. de Moreno de LeBlanc, A.; Castillo, N.A. and Perdigon, G. (2010) Anti-infective mechanisms induced by a probiotic lactobacillus strain against Salmonella enterica serovarTtyphimurium infection. Int. J. Food Microbiol., 138, 223-231.
38. Castillo, N.A.; Perdigon G. and de Moreno de Leblanc A. (2011) Oral administration of a probiotic lactobacillus modulates cytokine production and tlr expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiol., 11, 177.
39. Castillo, N.A.; de Moreno de LeBlanc A.; C M.G. and Perdigon G. (2013) Comparative study of the protective capacity against salmonella infection between probiotic and nonprobiotic lactobacilli. J. Appl. Microbiol., 114, 861-876.
40. Medici, M.; Vinderola, C.G.; Weill, R. and Perdigon, G. (2005) Effect of fermented milk containing probiotic bacteria in the prevention of an enteroinvasive escherichia coli infection in mice. J. Dairy Res., 72, 243-249.
41. de Moreno de LeBlanc, A.; Galdeano C.M.; Dogi, C.A.; Carmuega E.; Weill, R. and Perdigon, G. (2010) Adjuvant effect of a probiotic fermented milk in the protection against Salmonella enteritidis serovar Typhimurium infection: Mechanisms involved. Int. J. Immunopathol. Pharmacol., 23, 1235-1244.
42. Green, S.J.; Crawford, R.M.; Hockmeyer, J.T.; Meltzer, M.S. and Nacy C.A. (1990) Leishmania major amastigotes initiate the larginine- dependent killing mechanism in ifn-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J. Immunol., 145, 4290-4297.
43. Totemeyer, S.; Foster, N.; Kaiser, P.; Maskell, D.J. and Bryant, C.E. (2003) Toll-like receptor expression in C3h/hen and C3h/hej mice during Salmonella enterica serovar Typhimurium infection. Infect.Immun., 71, 6653-6657.
44. Galdeano, C.M.; Nunez, I.N.; de Moreno de LeBlanc, A.; Carmuega, E.; Weill, R. and Perdigon, G. (2011) Impact of a probiotic fermented milk in the gut ecosystem and in the systemic immunity using a non-severe protein-energy-malnutrition model in mice. BMC Gastroenterol., 11, 64.
45. Park, J.H.; Um, J.I.; Lee, B.J.; Goh, J.S.; Park, S.Y.; Kim, W.S. and Kim, P.H. (2002) Encapsulated bifidobacterium bifidum potentiates intestinal iga production. Cell Immunol., 219, 22-27.
46. Gill, H.S.; Rutherfurd, K.J.; Prasad, J. and Gopal, P.K. (2000) Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr., 83, 167-176.
47. Yasui, H.; Kiyoshima, J.; Hori, T. and Shida, K. (1999) Protection against influenza virus infection of mice fed bifidobacterium breve yit4064. Clin. Diagn. Lab Immunol., 6, 186-192.
48. Shu, Q. and Gill, H.S. (2001) A dietary probiotic (bifidobacterium lactis hn019) reduces the severity of escherichia coli o157:H7 infection in mice. Med. Microbiol. Immunol., 189, 147-152.
49. Gauffin, C.P.; Aguero, G.; Perdigon, G. (2002). Adjuvant effects of Lactobacillus casei added to a renutrition diet in a malnourished mouse model. Biocell., 26, 35-48.
50. Nunez, I.N.; Galdeano, C.M.; Carmuega, E.; Weill, R.; de Moreno de LeBlanc, A. and Perdigon, G. (2013) Effect of a probiotic fermented milk on the thymus in BALB/c mice under non-severe protein-energy malnutrition. Br. J. Nutr., 110, 500-508.
51. Reyed, M. (2007) The role of bifidobacteria in health. Res. J. Med. Sci., 2, 14-24.
52. Williams, A.M.; Probert, C.S.; Stepankova, R.; Tlaskalova- Hogenova, H.; Phillips, A. and Bland, P.W. (2006) Effects of microflora on the neonatal development of gut mucosal t cells and myeloid cells in the mouse. Immunol., 119, 470-478.
53. Woodmansey, E.J. (2007) Intestinal bacteria and ageing. J. Appl. Microbiol., 102, 1178-1186.
54. Husband, A.J. and Gleeson M. (1996) Ontogeny of mucosal immunity--environmental and behavioral influences. Brain Behav. Immun., 10, 188-204.
55. Hart, A.L.; Lammers, K.; Brigidi, P.; Vitali, B.; Rizzello, F.; Gionchetti, P.; Campieri, M.; Kamm, M.A.; Knight, S.C. and Stagg, A.J. (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut, 53, 1602-1609.
56. de Moreno de LeBlanc, A.; Dogi, C.A.; Galdeano, C.M.; Carmuega, E.; Weill, R. and Perdigon, G. (2008) Effect of the administration of a fermented milk containing Lactobacillus casei DN-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity. BMC Immunol., 9, 27.
57. Isolauri, E.; Salminen, S. and Ouwehand, A.C. (2004) Microbialgut interactions in health and disease. Probiotics. Best Pract. Res. Clin. Gastroenterol., 18, 299-313.
58. de Moreno de LeBlanc, A.; Chaves, S. and Perdigon, G. (2009) Effect of yoghurt on the cytokine profile using a murine model of intestinal inflammation. Eur. J. Inflamm., 7, 97-109.
59. Chaves, S.; Perdigon, G. and de Moreno de LeBlanc, A. (2011) Yoghurt consumption regulates the immune cells implicated in acute intestinal inflammation and prevents the recurrence of the inflammatory process in a mouse model. J. Food Prot., 74, 801- 811.
60. Perdigon, G.; de Moreno de LeBlanc, A.; Valdez, J. and Rachid, M. (2002) Role of yoghurt in the prevention of colon cancer. Eur. J. Clin. Nutr., 56 Suppl 3, S65-S68.
61. Isaacson, P. (1982) Immunoperoxidase study of the secretory immunoglobulin system and lysozyme in normal and diseased gastric mucosa. Gut, 23, 578-588.
62. de Moreno de Leblanc, A. and Perdigon G. (2004) Yogurt feeding inhibits promotion and progression of experimental colorectal cancer. Med Sci Monit 10, BR96-104.
63. de Moreno de LeBlanc, A.; Valdez, J. and Perdigón, G. (2004) Inflammatory immune response. Eur. J. Inflamm., 2, 21-31.
64. de Moreno de LeBlanc, A. and Perdigon, G. (2005) Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell., 29, 15-24.
65. Verma, A. and Shukla, G. (2013) Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMHinduced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in sprague dawley rats. Nutr. Cancer, 65, 84-91.